Brain nerve growth factor unbalance induced by anabolic androgenic steroids in rats

Medicine and Science in Sports and Exercise

Volumn 45, Issue 1, 2013, Pages 29-35

  Pieretti, Stefano ^a   Mastriota, Marica ^a   Tucci, Paolo ^b   Battaglia, Giuseppe ^c   Trabace, Luigia ^b   Nicoletti, Ferdinando ^c,d   Scaccianoce, Sergio ^d  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c IRCCS NEUROMED   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

anabolic androgenic steroids; basal forebrain; hippocampus; Nerve growth factor; neurotrophic unbalance; ngf receptors

Indexed keywords

ANABOLIC AGENT; ANDROGEN; BIOLOGICAL MARKER; CHOLINE ACETYLTRANSFERASE; NANDROLONE; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; PERFORMANCE ENHANCING SUBSTANCE; PROTEIN TYROSINE KINASE A; STANOZOLOL; TNFRSF16 PROTEIN, RAT;

ANIMAL; ARTICLE; DRUG ADMINISTRATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FOREBRAIN; HIPPOCAMPUS; MALE; MAZE TEST; MEMORY; METABOLISM; RAT; WESTERN BLOTTING; WISTAR RAT;

ANABOLIC AGENTS; ANDROGENS; ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CHOLINE O-ACETYLTRANSFERASE; DRUG ADMINISTRATION SCHEDULE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY; NANDROLONE; NERVE GROWTH FACTOR; PERFORMANCE-ENHANCING SUBSTANCES; PROSENCEPHALON; RATS; RATS, WISTAR; RECEPTOR, TRKA; RECEPTORS, NERVE GROWTH FACTOR; STANOZOLOL;

EID: 84871609607     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0b013e31826c60ea     Document Type: Article

References (40)

1. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem. 1976;72:248-54.
2. Breuer ME, McGinnis MY, Lumia AR, Possidente BP. Aggression in male rats receiving anabolic androgenic steroids: effects of social and environmental provocation. Horm Behav. 2001;40(3):409-18. (Pubitemid 33063569)
3. Capsoni S, Ugolini G, Comparini A, Ruberti F, Berardi N, Cattaneo A. Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc Natl Acad Sci USA. 2000; 97(12):6826-31. (Pubitemid 30412799)
4. Caraci F, Pistarà V, Corsaro A, et al. Neurotoxic properties of the anabolic androgenic steroids nandrolone and methandrostenolone in primary neuronal cultures. J Neurosci Res. 2011;89(4):592-600.
5. Cavalcante WL, Dal Pai-Silva M, Gallacci M. Effects of nandrolone decanoate on the neuromuscular junction of rats submitted to swimming. Comp Biochem Physiol C Toxicol Pharmacol. 2004; 139(4):219-24. (Pubitemid 40430775)
6. Charles V, Mufson EJ, Friden PM, Bartus RT, Kordower JH. Atrophy of cholinergic basal forebrain neurons following excitotoxic cortical lesions is reversed by intravenous administration of an NGF conjugate. Brain Res. 1996;728(2):193-203. (Pubitemid 26252812)
7. Clark AS, Lindenfeld RC, Gibbons CH. Anabolic-androgenic steroids and brain reward. Pharmacol Biochem Behav. 1996;53(3): 741-5. (Pubitemid 26086459)
8. Cooper JD, Salehi A, Delcroix JD, et al. Failed retrograde transport of NGF in a mouse model of Down-s syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Proc Natl Acad Sci USA. 2001;98(18):10439-44.
9. Daly RC, Su TP, Schmidt PJ, Pagliaro M, Pickar D, Rubinow DR. Neuroendocrine and behavioral effects of high-dose anabolic steroid administration in male normal volunteers. Psychoneuroendocrinology. 2003;28(3):317-31. (Pubitemid 36164951)
10. Deiana S, Platt B, Riedel G. The cholinergic system and spatial learning. Behav Brain Res. 2011;221(2):389-411.
11. Dekker AJ, Langdon DJ, Gage FH, Thal LJ. NGF increases cortical acetylcholine release in rats with lesions of the nucleus basalis. Neuroreport. 1991;2(10):577-80.
12. Feldkoren BI, Andersson S. Anabolic-androgenic steroid interaction with rat androgen receptor in vivo and in vitro: a comparative study. J Steroid Biochem Mol Biol. 2005;94(5):481-7. (Pubitemid 40626770)
13. Fudalai PJ, Weinrieb RM, Calarco JS, Kampman KM, Boardman C. An evaluation of anabolic-androgenic steroid abusers over a period of 1 year: seven case studies. Ann Clin Psychiatry. 2003; 15(2):121-30. (Pubitemid 38101803)
14. Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004;34(8):513-54. (Pubitemid 38981844)
15. Hefti F, Hartikka J, Eckenstein F, Gnahn H, Heumann R, Schwab M. Nerve growth factor increases choline acetyltransferase but not survival or fibre outgrowth of cultured fetal septal cholinergic neurons. Neuroscience. 1985;14(1):55-68. (Pubitemid 15124283)
16. Hendry IA, Stöckel K, Thoenen H, Iversen LL. The retrograde axonal transport of nerve growth factor. Brain Res. 1974;68(1): 103-21.
17. Holterhus PM, Piefke S, Hiort O. Anabolic steroids, testosteroneprecursors and virilizing androgens induce distinct activation profiles of androgen responsive promoter constructs. J Steroid Biochem Mol Biol. 2002;82(4-5):269-75. (Pubitemid 36187397)
18. Holtzman DM, Santucci D, Kilbridge J, et al. Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc Natl Acad Sci USA. 1996;93(23):13333-8. (Pubitemid 26382816)
19. Jiang B, Liao EY, Tan LM, Dai RC, Xiao ZJ, Liao HJ. Effects of long-term replacement therapy of compound nylestriol tablet or low-dose 17 beta-estradiol on the expression of nerve growth factor in OVX rat hippocampal formation. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2004;29(5):529-33.
20. Kicman AT. Pharmacology of anabolic steroids. Br J Pharmacol. 2008;154(3):502-21. (Pubitemid 351744954)
21. Lee TH, Kato H, Pan LH, Ryu JH, Kogure K, Itoyama Y. Localization of nerve growth factor, trkA and P75 immunoreactivity in the hippocampal formation and basal forebrain of adult rats. Neuroscience. 1998;83(2):335-49.
22. Long SF, Wilson MC, Sufka KJ, Davis WM. The effects of cocaine and nandrolone co-administration on aggression in male rats. Prog Neuropsychopharmacol Biol Psychiatry. 1996;20(5):839-56. (Pubitemid 26261914)
23. Magnusson K, Hånell A, Bazov I, Clausen F, Zhou Q, Nyberg F. Nandrolone decanoate administration elevates hippocampal prodynorphin mRNA expression and impairs Morris water maze performance in male rats. Neurosci Lett. 2009;467(3):189-93.
24. Matrisciano F, Modafferi AM, Togna GI, et al. Repeated anabolic androgenic steroid treatment causes antidepressant-reversible alterations of the hypothalamic-pituitary-adrenal axis, BDNF levels and behavior. Neuropharmacology. 2010;58(7):1078-84.
25. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods. 1984;11(1):47-60. (Pubitemid 14088970)
26. Myhrer T. Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks. Brain Res Brain Res Rev. 2003;41(2-3):268-87. (Pubitemid 36355883)
27. Nguyen TL, Kim CK, Cho JH, Lee KH, Ahn JY. Neuroprotection signaling pathway of nerve growth factor and brain-derived neurotrophic factor against staurosporine induced apoptosis in hippocampal H19-7/IGF-IR. Exp Mol Med. 2010;42(8):583-95.
28. Orlando R, Caruso A, Molinaro G, et al. Nanomolar concentrations of anabolic-androgenic steroids amplify excitotoxic neuronal death in mixed mouse cortical cultures. Brain Res. 2007;1165:21-9. (Pubitemid 47210972)
29. Parkinson AB, Evans NA. Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc. 2006;38(4):644-51.
30. Reeves RH, Irving NG, Moran TH, et al. A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet. 1995;11(2):177-84.
31. Sarkey S, Azcoitia I, Garcia-Segura LM, Garcia-Ovejero D, DonCarlos LL. Classical androgen receptors in non-classical sites in the brain. Horm Behav. 2008;53(5):753-64.
32. Schecterson LC, Bothwell M. Neurotrophin receptors: old friends with new partners. Dev Neurobiol. 2010;70(5):332-8.
33. Schliebs R, Arendt T. The cholinergic system in aging and neuronal degeneration. Behav Brain Res. 2011;221(2):555-63.
34. Seiler M, Schwab ME. Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat. Brain Res. 1984;300(1):33-9. (Pubitemid 14104091)
35. Sofroniew MV, Howe CL, Mobley WC. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci. 2001;24:1217-81. (Pubitemid 32695259)
36. Su TP, Pagliaro M, Schmidt PJ, Pickar D, Wolkowitz O, Rubinow DR. Neuropsychiatric effects of anabolic steroids in male normal volunteers. JAMA. 1993;269(21):2760-4. (Pubitemid 23154250)
37. Takahashi M, Tatsugi Y, Kohno T. Endocrinological and pathological effects of anabolic-androgenic steroid in male rats. Endocr J. 2004;51(4):425-34. (Pubitemid 39273453)
38. Tirassa P, Thiblin I, Agren G, Vigneti E, Aloe L, Stenfors C. High-dose anabolic androgenic steroids modulate concentrations of nerve growth factor and expression of its low affinity receptor (p75-NGFr) in male rat brain. J Neurosci Res. 1997; 47(2):198-207. (Pubitemid 27053378)
39. Verdi JM, Birren SJ, Ibáñez CF, et al. p75LNGFR regulates Trk signal transduction and NGF-induced neuronal differentiation in MAH cells. Neuron. 1994;12(4):733-45.
40. Wu YW, Kou XX, Bi RY, et al. Hippocampal nerve growth factor potentiated by 17A-estradiol and involved in allodynia of inflamed TMJ in rat. J Pain. 2012;13(6):555-63.